Farmak has launched a new ophthalmic product, Vial Tear eye drops (10 ml), at the market.
The drug is used to prevent and eliminate symptoms of irritation or burning in dry and tired eyes caused by various factors, as well as to protect against further irritation.
Yevgen Shlapak, Marketing Consultant, Farmak, says, “Almost 500,000 vials of ophthalmic drugs to hydrate the mucous membrane of the eye are sold every year. These are so-called "artificial tears", which are to be found in the first-aid kit of every contact lens wearer.
Ophthalmologists recommend using "artificial tears" for treatment of the dry eye syndrome*. Statistically, this syndrome predominantly affects elderly people (60% of all patients) with vitamin deficiency, endocrine disorders, menopause, chronic diseases of the eye, kidneys and blood vessels. Long-term use of certain drugs (antihypertensives, antiarrhythmics) induces dehydration, impairs production of body fluid, which leads to increased viscosity of tears and decrease in their total volume”.
Oksana Yefremova, Marketing Consultant, OTC Drugs Marketing Department, Farmak, says, “Vial Tear may also be used:
*The dry eye syndrome has external symptoms resembling inflammation. This syndrome is accompanied by the following manifestations: redness of the eyes, sandy, gritty sensations, smarting eyes, burning sensation, although they are caused not by infection but impaired wetting of the cornea.
За результатами ХХ конкурсу професіоналів фармацевтичної галузі України “Панацея”. 18 вересня відбулася церемонія нагородження переможців XX конкурсу професіоналів фармацевтичної галузі України «Панацея 2019». «Фармак» став переможцем конкурсу у номінації «Компанія року» “Нещодавно відбулася щорічна зустріч Ялтинської Європейської Стратегії...
The sports event “Farmak: Run for Your Health!” was held by Farmak for the third time on the occasion of Shostka Town Day, with support of the municipal authorities This year, the event was expanded. A new distance called FARMAK MORE RUN was created. It’s a 500 m race for participants under 12. A total […]
The preparatory hearing in the case regarding the well-known trademark Corvalol Corvalolum was held on August 28. The court considered the motion of the plaintiff PJSC Pharmaceutical Firm “Darnitsa” for involving JSC “Farmak” as a co-defendant in the case and the request of JSC “Farmak” for attaching the conclusion of sociological survey of consumers regardi...